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Kathryn B. Garber1,*Huntington Disease: Not Just Polyglutamine
Anymore
As the term polyQ disorder implies, Huntington disease
(HD) is thought to be due almost exclusively to the
toxicity of the expanded polyglutamine-containing tract
in the open-reading frame of the gene. For some other
trinucleotide repeat disorders caused by repeat expansions
outside of the open-reading frame, repeat-associated non-
ATG (RAN) translation has been implicated in disease
pathogenesis, leading Laura Ranum and colleagues to
explore whether this atypical form of protein translation
has a role in HD. They demonstrate the accumulation of
both sense and antisense RAN translation products in
cell culture, a mouse model, and human brains affected
by HD. These RAN products are toxic to neuronal cells,
are present in the brain regions most affected by HD,
and can be found in some regions in the absence of
detectable polyglutamine, leading Ranum and colleagues
to conclude that polyglutamine might be just one piece
of the HD puzzle.
Ban˜ez-Coronel et al. (2015). RAN translation in Huntington
disease. Neuron 88:667–677.Germline Mutations and Pediatric Cancer
A substantial fraction of children with cancer have pre-
disposing mutations in hereditary cancer genes, accord-
ing to recent work by Zhang et al. In a sample of
more than 1,000 children with a variety of cancers,
8.5% had putative pathogenic or likely pathogenic vari-
ation in any of 60 autosomal-dominant hereditary can-
cer genes. This ranged from about 4% of patients with
leukemia to 69% of those with adrenocortical tumors.
For comparison, just over 1% of samples in the 1000
Genomes sample had similar variants. Many of these
children would not be detected through family history
because a notable history is present in a similar fraction
of children with germline mutations as in those without
(40%).
Zhang et al. (2015). Germline mutations in predis-
position genes in pediatric cancer. New Eng. J. Med. Published
online November 18, 2015. http://dx.doi.org/10.1056/
NEJMoa1508054.1Department of Human Genetics, Emory University School of Medicine, Atlan
*Correspondence: kgarber@genetics.emory.edu
http://dx.doi.org/10.1016/j.ajhg.2015.12.005. 2016 by The American Societ
ThMutations on the Brain
Genetic analyses are most often based on DNA from blood
or saliva samples and are assumed to reflect the genetic
constitution of the whole body. Although we know that
somatic mutation occurs, such mutations will remain hid-
den unless they happen to show up in blood. D’Gama et al
were interested in the genetic variation underlying autism.
Concerned that blood samples might only reveal part of
the relevant genetic variation, they sequenced DNA from
postmortem brain samples of autistic individuals and
focused their analysis on 78 genes implicated in autism.
A high depth of sequence allowed them to detect somatic
variation that was predicted to be deleterious and was not
necessarily present in all brain regions. Despite a sample
size of only 55 affected individuals, they identified two
with putative deleterious somatic variation and one with
mosaic expansion from a fragile X premutation to a full
mutation, suggesting that somatic mutations play a role
in some cases of autism.
D’Gama et al. Targeted DNA sequencing from autism spec-
trum disorder brains implicates multiple genetic mechanisms.
Neuron 88: 910-917.Escape from DMD
A golden retriever model is one of the closest recapitula-
tions of Duchenne muscular dystrophy (DMD) in an ani-
mal. Affected dogs have a dystrophin splice mutation
that leads to loss of protein expression, and the dogs gener-
ally die by age two. Mayana Zatz and colleagues in Brazil
noticed that two dogs in their colony did not express dys-
trophin but remained ambulatory and did not succumb to
the disease at the expected age. Working with Lou Kunkel’s
group, the researchers used a combination of gene map-
ping and gene expression studies to implicate Jagged1 as
the gene responsible for the escape from the ravages of
muscular dystrophy in the dog colony. A single base
substitution upstream of Jagged1 creates a muscle-specific
transcription-factor binding site that fosters Jagged1 over-
expression. This, in turn, appears to increase the prolifera-
tive capacity of myoblasts in the dogs, which might
explain why their phenotype is so atypical for the dystro-
phin mutation. The role of Jagged1 is supported byta, GA 30322, USA
y of Human Genetics. All rights reserved.
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experiments in a zebrafish DMD model in which overex-
pression of Jagged1 also rescues the phenotype of affected
fish. Many strategies for treatment of DMD attempt to
induce expression of dystrophin. This work suggests Jag-
ged1 as an alternative target for intervention.
Vieira et al. (2015). Jagged 1 rescues the Duchenne muscular
dystrophy phenotype. Cell 163: 1204–1213
Placental Imprinting Defects in Hydatidiform
Moles
Most complete hydatidiform moles are sporadic and result
from a diploid genome that is entirely from the father. In
rare cases, hydatidiform moles are recurrent and result
from Mendelian mutations, most often in NLRP7. Rather
than being in the conceptus, the relevant mutations are
actually found in the constitutional genome of themother.
To better understand how NLRP7 mutations lead to molar4 The American Journal of Human Genetics 98, 3–4, January 7, 2016pregnancy, Sanchez-Delgado and colleagues compared
methylation profiles from common hydatidiform moles
with those from families with NLRP7 mutations. Whereas
the women carrying NLRP7mutations had typical methyl-
ation profiles in DNA from their blood, the researchers
discovered a failure of maternal methylation at placenta-
specific imprinted loci in the recurrent moles. This absence
of methylation leads to inappropriate biparental expres-
sion of alleles at these loci. Presumably, NLRP7 is key for es-
tablishing or maintaining maternal methylation patterns
in oocytes or pre-implantation embryos. Loss of this activ-
ity causes one of the most severe imprinting defects
known.
Sanchez-Delgado et al. (2015). Absence of maternal methyl-
ation in biparental hydatidiform moles from women with
NLRP7 maternal-effect mutations reveals widespread
placenta-specific imprinting. PLOS Genet. http://dx.doi.org/
10.1371/journal.pgen.1005644.This Month in Our Sister JournalStructural Variation Mapped with Long,
Fluorescently Labeled DNA
The short reads that are produced from next-generation
DNA sequencing impair our ability to discern structural
variation. Mak et al. developed a genomemappingmethod
that assesses structural variation in individual genomes
with a resolution of 5 kb. Their approach starts with
DNA molecules hundreds of thousands of base pairs
long, a size that generally maintains structural variation.
The molecules are fluorescently labeled at a specific
sequence motif and run on a nanochannel array, and thelocations of the fluorescent labels are imaged. Individual
molecule maps are then aligned to generate a genome
map from a single experiment. This alignment is based
on the identity of the labeled sequence motif and the dis-
tance between labels. The authors present data from a trio
from the 1000 Genomes collection; these individuals have
much more structural variation than previously reported,
including some that disrupts genes.
Mak et al. (2015). Genome-wide structural variation detec-
tion by genome mapping on nanochannel arrays. Genetics.
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